🇮🇹 Braftovi in Italy

Braftovi (encorafenib) regulatory status in Italy.

Marketing authorisation

AIFA

  • Local brand name: Braftovi
  • Status: approved

Braftovi in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Oncology approved in Italy

Frequently asked questions

Is Braftovi approved in Italy?

Yes. AIFA has authorised it.

Who is the marketing authorisation holder for Braftovi in Italy?

Pfizer is the originator. The local marketing authorisation holder may differ — check the official source linked above.